Although elevated brain Aβ levels can be observed in many individuals without cognitive decline, tau protein accumulation is a more reliable indicator of cognitive deterioration and is strongly associated with Alzheimer’s disease (AD) diagnosis. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.